Browse the corpus

REFERENCES Browning Carmo KA, Barr P, West M, et al, "Transporting Newborn Infants With Suspected Duct Dependent Congenital Heart Disease on Low-Dose Prostaglandin E1 Without Routine Mechanical Ventilation," Arch Dis Child Fetal Neonatal Ed , 2007, 92(2):F117-9. [PubMed 16905574 ] Institute for Safe Medication Practices (ISMP), "Standard Concentrations of Neonatal Drug Infusions," ISMP , 2011. Kaufman MB and El-Chaar GM, “Bone and Tissue Changes Following Prostaglandin Therapy in Neonates,” Ann Pharmacother , 1996, 30(3):269-74, 277. [PubMed 8833563 ] Lewis AB, Freed MD, Heymann MA, et al, “Side Effects of Therapy With Prostaglandin E 1 in Infants With Critical Congenital Heart Disease,” Circulation , 1981, 64(5):893-8. [PubMed 7285304 ] Peled N, Dagan O, Babyn P, et al, “Gastric-Outlet Obstruction Induced by Prostaglandin Therapy in Neonates,” N Engl J Med , 1992, 327(8):505-10. [PubMed 1635565 ] Phillips MS, "Standardizing I.V. Infusion Concentrations: National Survey Results," Am J Health Syst Pharm , 2011, 68(22):2176-82. [PubMed 22058104 ] Stone DM, Frattarelli DA, Karthikeyan S, et al, "Altered Prostaglandin E1 Dosage During Extracorporeal Membrane Oxygenation in a Newborn With Ductal-Dependent Congenital Heart Disease," Pediatr Cardiol , 2006, 27(3):360-3. [PubMed 16565906 ] Weesner KM, “Hemodynamic Effects of Prostaglandin E 1 in Patients With Congenital Heart Disease and Pulmonary Hypertension,” Cathet Cardiovasc Diagn , 1991, 24(1):10-5. [PubMed 1913785 ] Woo K, Emery J, and Peabody J, “Cortical Hyperostosis: A Complication of Prolonged Prostaglandin Infusion in Infants Awaiting Cardiac Transplantation,” Pediatrics , 1994, 93(3):417-20. [PubMed 8115200 ] Topic 13353 Version 37.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1105-199.231.185.123-90A40F4040-S244013.14]